
Phase 1a data in 16 patients with recurrent glioblastoma established a recommended dose for expansion of LP-184 for a planned phase 1b/2a combination trial.
A 35-year-old man presented with a lightly pigmented lesion on the skin of the right arm. Complete surgical excision of the lesion was performed.
What is your diagnosis?






